
EAN 2026: Real-world data supports safety and efficacy of AbbVie’s Vyalev in Parkinson’s
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOUHRUWmZwMHJvenU4X1pXQnl6cDg2OUJYaTJkNWEzOUJNN2xDZEprU2c0T2F5VUQ1RWlvYXQxdEZVYWN2RUd4eS1lUkt2QVV6OUR5S3c0VE9fLUg1QXE2Z0VhNjd1VDVmOEtKamtVS0NzS3lLenhlV1hfU0hMTGF0RW95R0V0VUJnYlFLamZBcWhZbUlLWEpZ?oc=5" target="_blank">EAN 2026: Real-world data supports safety and efficacy of AbbVie’s Vyalev in Parkinson’s</a>&nbsp;&nbsp;<font color="#6f6f6f">Clinical Trials Arena</font>
